Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Johns Hopkins University
With
Axogen Corporation
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
1. All patients presenting to Johns Hopkins who have had or will have mastectomy (therapeutic or prophylactic) and are planning to undergo unilateral mastectomy followed by breast reconstruction with autologous deep inferior epigastric perforator flap (DIEP) will be included.
These patients will then be randomized in either of two treatment modalities:
* Treatment Modality 1: Breast reconstruction with DIEP flap and neurotization.
* Treatment Modality 2: Breast reconstruction with DIEP flap but without neurotization.
2. 18 years of age and older
3. The patient is aware of the nature of her malignancy if a malignancy has been diagnosed; understands the study purpose, requirements, and risks; and is able and willing to sign an informed consent.
You may not be if
1. Autologous reconstruction where the flap is buried.
3. Pregnant or lactating women will be excluded from this study.
4. Women with recurrent breast cancer will be excluded.
5. Women with previous reconstructive procedures or who have previously undergone lumpectomy with radiation will be excluded.
